Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C (Study P04067)
NCT00727259
·
clinicaltrials.gov ↗
COMPLETED
Status
1995
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis C, Chronic
Interventions
BIOLOGICAL:
Peginterferon alfa-2b (SCH 54031)
DRUG:
Ribavirin (SCH 18908)
Sponsor
Merck Sharp & Dohme LLC